Boursorama “Le journal des Biotechs”

The interview is devoted to Laurence Rodriguez, appointed CEO of GenSight Biologics last December. It takes stock of the situation of the biotech specialist in gene therapy for neurodegenerative diseases of the retina and the central nervous system and sets out its strategic priorities in the short and medium term.